Cite

HARVARD Citation

    Mavroeidi, P. et al. (n.d.). EP-1288: Concurrent chemoradiaton(CCRT) for locally advanced/inflammatory or recurrent breast carcinoma(LABC). Radiotherapy and oncology. pp. S708-. [Online]. 
  
Back to record